Newsletter Signup | Join Community
Tony Corrente, NFL Referee and throat cancer survivor helps increase understanding and urges screening
The most common sexually transmitted infection in the U.S. has a bit of a twist.
Dr. Stephen Kang M.D. of The Ohio State University - James Cancer Hospital answers questions about head and neck cancer.
Erbitux alone or in combination with radiation or chemotherapy is effective treatment of advanced head & neck cancer.
Hypothyroidism can develop following treatment for head and neck cancer for several years after completing treatment.
Long term Follow up Confirms Success of MGH-developed Laser Treatment for Vocal-cord Cancer
Symptoms, Diagnosis, & Treatment of Salivary Gland Cancer
Overview of Throat Cancer: Symptoms, Diagnosis, & Treatment
Nimotuzumab in Combination With Concurrent Radiotherapy and Cisplatin Is Active in Locally Advanced SCCHN
Twice-daily radiation therapy reduces mortality from head and neck cancer
Larotrectinib Demonstrates 76 Percent Response Rate in TRK Fusion Cancers Including Those of the Salivary Gland
Fractionated Radiotherapy Improves Survival in Head and Neck Cancer.
Addition of Chemotherapy Improves Survival in Some Elderly Patients with Head and Neck Cancer
Compliance with Radiation Schedules Improves Survival in Head and Neck Cancer
Opdivo Approved for Advanced Head and Neck Cancer
Another Reason to Break the Habit: Smoking Alters Bacterial Balance in Mouth
Head and Neck Cancer Immunotherapy Study with AXAL Advances to Second Stage
A troublesome side effect of radiation therapy treatment of cancers involving the head and neck is dry mouth.
Better Outcomes in Oral Cancer with Surgery to Remove Lymph Nodes in Neck before Cancer Spreads
Adding Vectibix to Cisplatin/Fluorouracil Improves Progression-Free Survival in Recurrent or Metastatic Head&Neck Cancer
Lip & Oral Cavity Cancer: Symptoms, Diagnosis, & Treatment
Lymphoseek® Results from Phase 3 Clinical Trial in Oral Cavity Cancer of the Head and Neck
Combination of Avastin® and Tarceva® Shows Promise in Head and Neck Cancer
Accelerated Radiation Schedule May Improve Head and Neck Cancer Outcomes
Unilateral Radiation Effective for Squamous Cell Tonsil Cancer.
Gene Model Predicts Risk of Recurrence in Operable Laryngeal Cancer
Combined Treatment Provides Benefit for Nasopharyngeal Cancer
Mixed Findings on Combination Therapy for Nasopharyngeal Cancer
Aggressive Therapy Provides Benefit in Squamous Cell Carcinoma of the Head and Neck Despite Age.
Sequential and Alternating Chemotherapy and Radiation Therapy Similarly Effective for Larynx Cancer
Vectibix Does Not Improve Head and Neck Cancer Survival.
Proteins in Saliva May Detect Oral Cancer
Head and Neck Cancer Is Treatable in Elderly Patients
Family History Increases Risk of Oral and Pharyngeal Cancer
Advexin® Improves Survival in Head and Neck Cancer
Three-drug Combination Increases Rates of Larynx Preservation
Periodic CT Detects Pulmonary Metastases among Head and Neck Cancer Patients
Differences in IMRT Radiation Doses May Complicate Study Results in Head and Neck Cancer.
Uninsured Have Worse Head and Neck Cancer Survival
Chemotherapy plus Radiation Doubles Survival Time in Advanced Head and Neck Cancer
Addition of Taxotere® Improves Survival in Head and Neck Cancer.
Adding Erbitux® to Radiation Improves Survival in Head and Neck Cancer
TP53 Mutations Associated with Decreased Survival in Head and Neck Cancer
Periodontitis Linked to Increased Risk of Developing Cancer of the Tongue.
Endoscopic Laser Surgery Effective for Glottic Cancer Recurrence
Erbitux® Improves Survival in Head and Neck Cancers.
Aspiration Risk Assessment Recommended for Patients with Head and Neck Cancer
Addition of Radiation Improves Survival in Head and Neck Cancer.
Taxotere® Approved for Head and Neck Cancer
Insurance Status Influences Stage at Diagnosis of Breast and Oropharyngeal Cancers
Study Finds No Evidence that NSAIDS Reduce Risk of Oral Cancer.
Levels of ET-1 Help Predict Outcomes of Nasopharyngeal Cancer
Poorer Survival for Men with Head and Neck Cancer Who Live Alone
Response to Chemotherapy May Guide Treatment of Patients with Advanced Laryngeal Cancer
IMRT Improves Quality of Life for Nasopharyngeal Cancer
FDA Approves Erbitux® For Treatment of Head and Neck Cancer
Addition of Taxotere® to Chemotherapy Helps Preserve Function of Larynx
Low-Dose Isotretinoin Does Not Reduce Subsequent Tumors in Head and Neck Cancers
Smoking Marijuana Does Not Increase Risk of Lung or Head and Neck Cancers
Cryoblation May Help Preserve Voice in Glottic Cancer
Aspirin May Reduce Risk of Head and Neck Cancer
Markers of Tumor Oxygen Levels Linked with Response to Radiation Therapy in Head and Neck Cancer.
Taxotere® Approved for Treatment of Head and Neck Cancer
Rate of Second Cancers Increased with Radiation for Head and Neck Cancers
Chemotherapy plus Radiation Therapy Superior to Aggressive Radiation Therapy in Some Head and Neck Cancers
Patients with Head and Neck Cancer Have Higher Suicide Rates
Radiation Therapy and Combination Chemotherapy for Head and Neck Cancer
Treatment with Chemotherapy and Radiation Therapy at the Same Time Improves Outcomes in Head and Neck Cancer
Chemotherapy Followed by Taxotere® plus Radiation Provides Impressive Outcomes for Locally Advanced Head and Neck Cancer
Vitamin E Supplementation May Be Harmful in Head and Neck Cancer Patients
Addition of Taxotere® to Initial Therapy Improves Survival in Head and Neck Cancer
SNPs Help Determine Effectiveness of Platinol® in Head and Neck Cancers
DNA-repair Enzyme Linked with Likelihood of Head and Neck Cancer
Brachytherapy Improves Outcomes for Patients with Persistent Nasopharyngeal Cancer
Predicting Response of Head and Neck Cancer to Accelerated Radiation Therapy
Addition of Erbitux® to Radiation Therapy Improves Survival in Head and Neck Cancer
Meta-Analysis Indicates Improved Survival with Addition of Chemotherapy in Nasopharyngeal Cancer.
Vitamin E Does Not Reduce the Risk of a Second Cancer in Patients with Head and Neck Cancer
Epivir®-HBV Reduces Reactivation of Hepatitis B in Nasopharyngeal Cancer Patients
Tumor Protein Predicts Response of Head and Neck Cancer to Abraxane™
Immunotherapy Provides Responses in Refractory Nasopharyngeal Cancer
Advanced Head and Neck Cancer May Be Effectively Controlled with Radiation Therapy and Chemo Combo
Addition of Taxol® to Chemotherapy Combination Improves Survival in Unresectable, Locally Advanced Head and Neck Cancer
Targeted Therapy Injected Directly Into Cancer Appears Promising for Head and Neck Cancer
Fractionated Stereotactic Radiation Therapy Safely and Effectively Manages Acoustic Neuroma
Iressa® and Celebrex® Show Promise for Head and Neck Cancer
Addition of Eloxatin® to Radiation Improves Survival in Nasopharyngeal Cancer
Biomarkers in Blood Detect Oral Cancer
Radiosensitizer May Benefit Head and Neck Cancer Patients
Brachytherapy Improves Control of Cancers of the Tongue
Interstitial Photodynamic Therapy Effective in Recurrent Head and Neck Cancer
Addition of Brachytherapy to Chemotherapy and Radiation Provides High Responses in Nasopharyngeal Cancer
Cox-2 Expression Associated with Resistance to Radiation Therapy in Head and Neck Cancer
Addition of Cisplatin to Radiation Improves Survival in Head and Neck Cancer
EGFR Expression Associated with Poorer Prognosis in Advanced Nasopharyngeal Cancer
Ethyol® Allows Greater Tolerability of Chemotherapy in Head and Neck Cancer
Addition of Chemotherapy Improves Survival in Nasopharyngeal Cancer.
Genetically Engineered Mouthwash May Delay Oral Cancer
Addition of Chemotherapy to Radiation Improves Long-Term Survival in Patients with Oropharyngeal Cancer
Changes in Surrounding Cells Influence Growth of Head and Neck Cancer
Motexafin Gadolinium May Improve Responses to Therapy in Locally Advanced Head and Neck Cancer.
More Frequent Radiation Improves Progression-Free Survival in Head and Neck Cancer
Treatment Regimen may Improve Outcomes in Advanced Head and Neck Cancer
Researchers Evaluate Evidence and Suggest Guidelines for Use of Complementary and Alternative Medicine Therapies
Gene Therapy Appears Effective for Recurrent Head and Neck Cancer
Addition of Erythropoetin to Radiotherapy Does Not Improve Outcomes Among Anemic Patients with Head and Neck Cancers
Novel Neoadjuvant Chemotherapy Regimen Improves Responses in Locally Advanced Head and Neck Cancer
Stereotactic Radiation Augments Whole Brain Radiation in Cancer Spread to the Brain.
Intra-Arterial Chemotherapy Plus Hyperfractionated Radiation Effective for Advanced Head and Neck Cancer
Kava Herbal Medicine Banned in Britain and Germany, U.S. Relies on Warning Labels
Longer Follow-Up Needed to Determine if Chemotherapy in Addition to Radiation Following Surgery is Beneficial
Chinese Herbal Medicines Frequently Contaminated with Harmful Drugs
Ifosfamide, Cisplatin and Retinoic Acid Effective for Advanced Head and Neck Cancer
OSI-774 Shows Efficacy in Advanced Head and Neck Cancer
Radiation plus Chemotherapy Effective for Recurrent Head and Neck Cancer
RadiationTherapy with New Monoclonal Antibody, IMC-225, Produces Long-Lasting Responses in Persons with Locally Advanced
RadiationTherapy,Sometimes with Removal of Lymph Nodes,May Be as Effective as Extensive Surgery for Cancer of the Tonsil
Anemia Adversely Affects Outcomes in Nasopharyngeal Cancer
Locally Advanced Head & Neck Cancer: Cisplatin + Radiation Therapy Appears More Effective than Radiation Therapy Alone
Increased Radiation Therapy Reduces Cancer Recurrences in Patients with Head and Neck Cancer
Accelerated Boost Radiation Therapy Effective in Older Persons with Head and Neck Cancer
Protease Inhibitor Derived From Soybeans May Prevent Oral Cancer
Cancer of the Base of the Tongue: Radiation Therapy May Be Treatment of Choice
Intra-arterial Chemotherapy: A New Treatment Option for Head and Neck Cancer
Novel Therapy Prevents Recurrences In Patients with Locally Advanced Head and Neck Cancer
Head and Neck Cancer: New Chemotherapy Regimen Produces High Response Rates
Paclitaxel May Improve Treatment Options for Patients with Cancer of the Head and Neck
Docetaxel, Cisplatin, and Fluorouracil Produces a High Complete Response Rate in Patients with Cancer of the Head and Ne
Cancer of the Mouth and Throat: Adding Chemotherapy to Radiation Therapy Improves Effectiveness of Treatment
Tirapazamine Offers Promise for Treatment of Head and Neck Cancer
Combined Chemotherapy and Radiation Therapy Improves Survival in Patients with Advanced Cancer of the Mouth and Throat
Oral Contraceptive Use Not Associated with Increased Risk of Mortality.
CancerConnect News:Buffalo Bills Hall of Fame quarterback Jim Kelly has developed a recurrence of his head & neck cancer
New Approaches in the Treatment of Head and Neck Cancer: ESMO 2002October 18-22, 2002Nice,
Anemia Associated with Poor Anti-Cancer Responses to Treatment in Head and Neck Cancer
Some Head and Neck Cancer Patients Benefit From Continued Checkpoint Inhibitor Treatment After Tumor Growth
Sentinel Node Biopsy Safe and Effective for Melanomas on Head and Neck